The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
In order to compare baseline costs to savings and determine areas of compliance risk, supply chain professionals need to work closely with their…
Podcasts
Now that the entire healthcare field is increasing its focus on value-based care, supply chain and physicians are working more closely together.
Podcasts
In this session, Dennis Black and Dennis Orthman share their experiences and best practices to improve and expand the provider-supplier relationship.
e-Learning
Become an expert in health care inventory management with AHRMM's certification program. Gain the skills to optimize your supply chain. Enroll now!
Webcast
Part 3 of the GPO or Local/Self Contracting webcast series examines whether compliance can be achieved without alignment, and vice versa.
On-Demand Educational Webinars
At Hershey Penn State Medical Center, the supply chain and ED nursing team came together in a Kaizen process to reinvent the way supplies were being…